OPKO Health ROE 2010-2024 | OPK
OPKO Health ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2024-09-30 | $-0.13B | $1.40B | -9.78% |
2024-06-30 | $-0.24B | $1.40B | -17.66% |
2024-03-31 | $-0.25B | $1.25B | -17.93% |
2023-12-31 | $-0.19B | $1.39B | -12.70% |
2023-09-30 | $-0.21B | $1.45B | -13.59% |
2023-06-30 | $-0.21B | $1.54B | -13.32% |
2023-03-31 | $-0.29B | $1.55B | -18.01% |
2022-12-31 | $-0.33B | $1.56B | -20.11% |
2022-09-30 | $-0.32B | $1.63B | -19.07% |
2022-06-30 | $-0.20B | $1.72B | -11.91% |
2022-03-31 | $-0.12B | $1.62B | -6.81% |
2021-12-31 | $-0.03B | $1.69B | -1.74% |
2021-09-30 | $0.08B | $1.77B | 4.42% |
2021-06-30 | $0.07B | $1.74B | 4.22% |
2021-03-31 | $0.12B | $1.70B | 7.35% |
2020-12-31 | $0.03B | $1.67B | 1.93% |
2020-09-30 | $-0.11B | $1.62B | -7.09% |
2020-06-30 | $-0.20B | $1.59B | -12.45% |
2020-03-31 | $-0.29B | $1.55B | -17.99% |
2019-12-31 | $-0.32B | $1.62B | -18.72% |
2019-09-30 | $-0.28B | $1.64B | -16.16% |
2019-06-30 | $-0.25B | $1.71B | -13.90% |
2019-03-31 | $-0.19B | $1.76B | -10.68% |
2018-12-31 | $-0.15B | $1.79B | -8.48% |
2018-09-30 | $-0.30B | $1.79B | -16.24% |
2018-06-30 | $-0.30B | $1.81B | -16.02% |
2018-03-31 | $-0.31B | $1.82B | -15.97% |
2017-12-31 | $-0.31B | $1.84B | -15.02% |
2017-09-30 | $-0.13B | $2.09B | -5.96% |
2017-06-30 | $-0.10B | $2.11B | -4.95% |
2017-03-31 | $-0.07B | $2.11B | -3.41% |
2016-12-31 | $-0.05B | $2.09B | -2.34% |
2016-09-30 | $-0.01B | $2.11B | -0.44% |
2016-06-30 | $0.13B | $2.02B | 6.73% |
2016-03-31 | $0.08B | $2.00B | 4.43% |
2015-12-31 | $-0.03B | $1.98B | -2.15% |
2015-09-30 | $-0.09B | $1.97B | -7.65% |
2015-06-30 | $-0.26B | $0.83B | -31.16% |
2015-03-31 | $-0.24B | $0.81B | -28.30% |
2014-12-31 | $-0.17B | $0.84B | -19.84% |
2014-09-30 | $-0.14B | $0.89B | -15.53% |
2014-06-30 | $-0.15B | $0.91B | -16.87% |
2014-03-31 | $-0.13B | $0.83B | -17.34% |
2013-12-31 | $-0.12B | $0.87B | -19.38% |
2013-09-30 | $-0.10B | $0.87B | -23.59% |
2013-06-30 | $-0.05B | $0.31B | -20.48% |
2013-03-31 | $-0.06B | $0.32B | -28.61% |
2012-12-31 | $-0.03B | $0.18B | -19.62% |
2012-09-30 | $-0.01B | $0.15B | -7.82% |
2012-06-30 | $-0.01B | $0.15B | -7.72% |
2012-03-31 | $-0.01B | $0.16B | -4.54% |
2011-12-31 | $-0.00B | $0.16B | -2.41% |
2011-09-30 | $-0.02B | $0.10B | -24.44% |
2011-06-30 | $-0.02B | $0.11B | -30.22% |
2011-03-31 | $-0.02B | $0.12B | -40.55% |
2010-12-31 | $-0.02B | $0.02B | -56.38% |
2010-09-30 | $-0.03B | $0.02B | -75.95% |
2010-06-30 | $-0.03B | $0.05B | -63.37% |
2010-03-31 | $-0.03B | $0.06B | -64.92% |
2009-12-31 | $-0.04B | $0.03B | -110.24% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $1.106B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $219.062B | 26.20 |
Intuitive Surgical (ISRG) | United States | $209.612B | 96.16 |
Alcon (ALC) | Switzerland | $45.206B | 30.25 |
Edwards Lifesciences (EW) | United States | $41.870B | 26.59 |
IQVIA Holdings (IQV) | United States | $38.108B | 20.48 |
IDEXX Laboratories (IDXX) | United States | $37.713B | 43.16 |
DexCom (DXCM) | United States | $34.497B | 51.95 |
Mettler-Toledo (MTD) | United States | $28.642B | 32.97 |
Waters (WAT) | United States | $24.401B | 36.08 |
STERIS (STE) | Ireland | $22.253B | 25.33 |
SONOVA HOLDING (SONVY) | Switzerland | $20.160B | 0.00 |
Hologic (HOLX) | United States | $14.774B | 15.85 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $14.260B | 14.64 |
Globus Medical (GMED) | United States | $11.976B | 30.33 |
Sysmex ADR (SSMXY) | Japan | $11.771B | 36.91 |
Penumbra (PEN) | United States | $10.036B | 98.31 |
Masimo (MASI) | United States | $9.638B | 46.64 |
Glaukos (GKOS) | United States | $8.562B | 0.00 |
Teleflex (TFX) | United States | $8.064B | 12.86 |
Integer Holdings (ITGR) | United States | $4.726B | 26.79 |
Inari Medical (NARI) | United States | $4.676B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $3.694B | 0.00 |
Veracyte (VCYT) | United States | $3.371B | 101.16 |
Nihon Kohden (NHNKY) | Japan | $2.700B | 14.76 |
LivaNova (LIVN) | United Kingdom | $2.605B | 15.04 |
TransMedics (TMDX) | United States | $2.467B | 78.19 |
Tandem Diabetes Care (TNDM) | United States | $2.413B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.332B | 20.97 |
Integra LifeSciences Holdings (IART) | United States | $2.008B | 10.49 |
Alphatec Holdings (ATEC) | United States | $1.620B | 0.00 |
RxSight (RXST) | United States | $1.353B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.340B | 0.00 |
Artivion (AORT) | United States | $1.311B | 86.86 |
Paragon 28 (FNA) | United States | $1.088B | 0.00 |
AxoGen (AXGN) | United States | $0.807B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.781B | 13.27 |
IRadimed (IRMD) | United States | $0.778B | 42.03 |
Mesa Laboratories (MLAB) | United States | $0.770B | 16.83 |
SiBone (SIBN) | United States | $0.725B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.706B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.640B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.574B | 0.00 |
Delcath Systems (DCTH) | United States | $0.526B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.521B | 0.00 |
Semler Scientific (SMLR) | United States | $0.463B | 24.35 |
AngioDynamics (ANGO) | United States | $0.449B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.438B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.412B | 22.30 |
NeuroPace (NPCE) | United States | $0.408B | 0.00 |
CVRx (CVRX) | United States | $0.357B | 0.00 |
Accuray (ARAY) | United States | $0.277B | 0.00 |
Inogen (INGN) | United States | $0.258B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.222B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.222B | 0.00 |
Nevro (NVRO) | United States | $0.214B | 0.00 |
Sight Sciences (SGHT) | United States | $0.138B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.133B | 0.00 |
LENSAR (LNSR) | United States | $0.126B | 0.00 |
Hyperfine (HYPR) | United States | $0.125B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.118B | 0.00 |
Neuronetics (STIM) | United States | $0.108B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.100B | 15.20 |
Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
908 Devices (MASS) | United States | $0.089B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
InspireMD (NSPR) | Israel | $0.068B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
Positron (POSC) | United States | $0.053B | 0.00 |
Microbot Medical (MBOT) | United States | $0.044B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.039B | 0.00 | |
Spectral AI (MDAI) | United States | $0.037B | 0.00 |
Precision Optics (POCI) | United States | $0.032B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.032B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.032B | 0.00 |
Envoy Medical (COCH) | United States | $0.032B | 0.00 |
NexGel (NXGL) | United States | $0.023B | 0.00 |
DarioHealth (DRIO) | United States | $0.021B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
PAVmed (PAVM) | United States | $0.007B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.006B | 0.00 |
Nuwellis (NUWE) | United States | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
Tenon Medical (TNON) | United States | $0.005B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.004B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |